AbramsD. S. (2008). Did TRIPS Spur innovation—An analysis of patent duration and incentives to innovate. University of Pennsylvania Law Review, 157(6), 1613–1647. https://scholarship.law.upenn.edu/penn_law_review/vol157/iss6/2
2.
AllredB. B., & ParkW. G. (2007). Patent rights and innovative activity: Evidence from national and firm-level data. Journal of International Business Studies, 38(6), 878–900. 10.1057/palgrave.jibs.8400306
3.
ArrowK. (1962). Economic welfare and the allocation of resources for invention. In Universities-National Bureau Committee for Economic and Council (Ed.), The rate and direction of inventive activity: Economic and social factors (pp. 609–626). Princeton University Press. https://www.nber.org/system/files/chapters/c2144/c2144.pdf
4.
BasheerS. (2012). The invention of an investment incentive for pharmaceutical innovation. The Journal of World Intellectual Property, 15(5–6), 305–364. 10.1111/jwip.12001
5.
BBC. (2021, May6). Covid: US backs waiver on vaccine patents to boost supply. https://www.bbc.com/news/world-us-canada-57004302
6.
BlindK. (2012). The influence of regulations on innovation: A quantitative assessment for OECD countries. Research Policy, 41(2), 391–400. 10.1016/j.respol.2011.08.008
7.
BondarevA. (2018). Does stronger intellectual property rights protection foster structural change? Effects of heterogeneity in innovations. Structural Change and Economic Dynamics, 46, 26–42. 10.1016/j.strueco.2018.03.005
8.
BouetD. (2015). A study of intellectual property protection policies and innovation in the Indian pharmaceutical industry and beyond. Technovation, 38, 31–41. 10.1016/j.technovation.2014.10.007
9.
BreitwieserA., & Foster-McGregorN. (2012). Intellectual property rights, innovation and technology transfer: A survey (WIIW Working Paper No. 88). https://wiiw.ac.at/intellectual-property-rights-innovation-and-technology-transfer-a-survey-p-2646.html
10.
ChadhaA. (2009). TRIPs and patenting activity: Evidence from the Indian pharmaceutical industry. Economic Modelling, 26(2), 499–505. 10.1016/j.econmod.2008.10.004
11.
ChaudhuriS. (2015). Intellectual property rights and innovation: MNCs in pharmaceutical industry in India after TRIPS (Institute for Studies in Industrial Development Working Paper No. 170). http://103.82.220.134/pdf/WP170.pdf
12.
ChenY., & PuttitanunT. (2005). Intellectual property rights and innovation in developing countries. Journal of Development Economics, 78(2), 474–493. 10.1016/j.jdeveco.2004.11.005
13.
ChoK., KimC., & ShinJ. (2015). Differential effects of intellectual property rights on innovation and economic performance: A cross-industry investigation. Science and Public Policy, 42(6), 827–840. 10.1093/scipol/scv009
14.
ChuA. C., FanH., ShenG., & ZhangX. (2018). Effects of international trade and intellectual property rights on innovation in China. Journal of Macroeconomics, 57, 110–121. 10.1016/j.jmacro.2018.05.003
15.
Di VitaG. (2013). The TRIPs agreement and technological innovation. Journal of Policy Modeling, 35(6), 964–977. 10.1016/j.jpolmod.2013.02.001
16.
Di VitaG. (2016). International strengthen of intellectual property rights, and financial markets development. Journal of Economics and Finance, 40(1), 60–67. 10.1007/s12197-014-9292-4
17.
EncaouaD., GuellecD., & MartínezC. (2006). Patent systems for encouraging innovation: Lessons from economic analysis. Research Policy, 35(9), 1423–1440. 10.1016/j.respol.2006.07.004
18.
EzzeddineS., & HammamiM. S. (2018). Nonlinear effects of intellectual property rights on technological innovation. Journal of Economic Integration, 33(2), 1337–1362. https://www.jstor.org/stable/26431810
19.
ForayD. (2009). Technology transfer in the TRIPS age (ICTSD Issue Paper No. 23). https://www.files.ethz.ch/isn/104405/2009_05_technology_trips.pdf
20.
GambaS. (2017). The effect of intellectual property rights on domestic innovation in the pharmaceutical sector. World Development, 99, 15–27. 10.1016/j.worlddev.2017.06.003
21.
GinarteJ. C., & ParkW. G. (1997). Determinants of patent rights: A cross-national study. Research Policy, 26(3), 283–301.
22.
GodinhoM. M., & FerreiraV. (2012). Analysing the evidence of an IPR take-off in China and India. Research Policy, 41(3), 499–511. 10.1016/j.respol.2011.09.009
23.
HaleyG. T., & HaleyU. C. (2012). The effects of patent-law changes on innovation: The case of India’s pharmaceutical industry. Technological Forecasting and Social Change, 79(4), 607–619. 10.1016/j.techfore.2011.05.012
24.
HammamiS. (2021). The effect of intellectual property protection on innovation: Empirical analysis of developing countries panel. African Journal of Science, Technology, Innovation and Development, 13(4), 397–405. 10.1080/20421338.2020.1824608
25.
HassanE., YaqubO., & DiepeveenS. (2010). Intellectual property and developing countries: A review of the literature. RAND. https://www.rand.org/content/dam/rand/pubs/technical_reports/2010/RAND_TR804.pdf
26.
HilaryW. (2020). The case for compulsory licensing during COVID-19. Journal of Global Health. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242884/
27.
HudsonJ., & MineaA. (2013). Innovation, intellectual property rights, and economic development: A unified empirical investigation. World Development, 46, 66–78. 10.1016/j.worlddev.2013.01.023
28.
IslamM. D., KaplanW. A., TrachtenbergD., ThrasherR., GallagherK. P., & WirtzV. J. (2019). Impacts of intellectual property provisions in trade treaties on access to medicine in low- and middle-income countries: A systematic review. Globalization and Health, 15(1), 1–14. 10.1186/s12992-019-0528-0
29.
JagadeeshH., & SasidharanS. (2014). Do stronger IPR regimes influence R&D efforts? Evidence from the Indian pharmaceutical industry. Global Business Review, 15(2), 189–204. 10.1177/0972150914523571
30.
KanwarS. (2007). Business enterprise R&D, technological change, and intellectual property protection. Economics Letters, 96(1), 120–126. 10.1016/j.econlet.2006.12.020
KieffF. S. (2000). Property rights and property rules for commercializing inventions. Minnesota Law Review, 85, 697–754. https://core.ac.uk/download/pdf/232644974.pdf
33.
KiranR., & MishraS. (2011). Research and development, exports and patenting in the Indian pharmaceutical industry: A post TRIPS analysis. Eurasian Journal of Business and Economics, 4(7), 53–67. https://ejbe.org/EJBE2011Vol04No07p53KIRAN-MISHRA.pdf
34.
KitchE. W. (1977). The nature and function of the patent system. The Journal of Law and Economics, 20(2), 265–290. https://www.jstor.org/stable/725193
35.
KleinknechtA., Van MontfortK., & BrouwerE. (2002). The non-trivial choice between innovation indicators. Economics of Innovation and New Technology, 11(2), 109–121. 10.1080/10438590210899
36.
KortumS., & LernerJ. (1999). What is behind the recent surge in patenting?Research Policy, 28(1), 1–22. 10.1016/S0048-7333(98)00082-1
37.
LernerJ. (2009). The empirical impact of intellectual property rights on innovation: Puzzles and clues. American Economic Review, 99(2), 343–348. https://www.jstor.org/stable/25592422
38.
LiuM., & La CroixS. (2014). The impact of stronger property rights in pharmaceuticals on innovation in developed and developing countries (University of Hawai’i Working Paper No. 14–17). https://www.economics.hawaii.edu/research/workingpapers/WP_14-7.pdf
39.
LoS. T. (2011). Strengthening intellectual property rights: Experience from the 1986 Taiwanese patent reforms. International Journal of Industrial Organization, 29(5), 524–536. 10.1016/j.ijindorg.2010.11.001
40.
LongC. (2002). Patent signals. The University of Chicago Law Review, 69(2), 625–679. https://www.jstor.org/stable/1600501
41.
MachlupF. (1958). An economic review of the patent system (No. 15). US Government Printing Office. https://cdn.mises.org/An%20Economic%20Review%20of%20the%20Patent%20System_Vol_3_3.pdf
42.
MazzoleniR., & NelsonR. R. (1998). The benefits and costs of strong patent protection: A contribution to the current debate. Research Policy, 27(3), 273–284. 10.1016/S0048-7333(98)00048-1
43.
MelkicE. (2019). Trips and the globalisation of patent protection: A comparative analysis of the effectiveness of compulsory licenses as a tool for improving access to cancer medicines (King’s College London Law School Graduate Student Research Paper, (2018/19), 04). http://dx.doi.org/10.2139/ssrn.3627375
44.
NaghaviA., & StrozziC. (2015). Intellectual property rights, diasporas, and domestic innovation. Journal of International Economics, 96(1), 150–161. 10.1016/j.jinteco.2015.01.007
45.
NordhausW. D. (1969). Invention, growth and welfare: A theoretical treatment of technological change. MIT Press.
46.
PapageorgiadisN., & SharmaA. (2016). Intellectual property rights and innovation: A panel analysis. Economics Letters, 141, 70–72. 10.1016/j.econlet.2016.01.003
47.
ParkW. G. (2008). International patent protection: 1960–2005. Research Policy, 37(4), 761–766.
48.
ParkW. G., & WaghS. (2002). Index of Patent Rights. In GwartneyJ. & LawsonR. (Eds.), Economic freedom of the world. The Fraser Institute, Vancouver.
49.
PazderkaB. (1999). Patent protection and pharmaceutical R&D spending in Canada. Canadian Public Policy, 25(1), 29–46. https://www.jstor.org/stable/3551400
50.
PeterK. Y. (2016). The comparative economics of international intellectual property agreements. In EisenbergT. & RamelloG. B. (Eds.), Comparative law and economics (pp. 282–310). Edward Elgar Publishing. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2334107
51.
PosnerR. A. (2012, July12). Why there are too many patents in America. The Atlantic. https://www.theatlantic.com/business/archive/2012/07/why-there-are-too-many-patents-in-america/259725/
52.
QianY. (2007). Do national patent laws stimulate domestic innovation in a global patenting environment? A cross-country analysis of pharmaceutical patent protection, 1978–2002. The Review of Economics and Statistics, 89(3), 436–453. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=1024829
53.
SchererF. M. (1967). Market structure and the employment of scientists and engineers. The American Economic Review, 57(3), 524–531. https://www.jstor.org/stable/1812118
54.
SchneiderP. H. (2005). International trade, economic growth and intellectual property rights: A panel data study of developed and developing countries. Journal of Development Economics, 78(2), 529–547. 10.1016/j.jdeveco.2004.09.001
55.
SchumpeterJ. (1942). Capitalism, socialism and democracy. Routledge
56.
ShantharamY. (2005). The cost of life: Patent laws, the WTO and the HIV/AIDS pandemic. Undercurrent, 2(2), 48–56. https://web.s.ebscohost.com/abstract?direct=true&profile=ehost&scope=site&authtype=crawler&jrnl=17120934&AN=18652215&h=KLiXgp88t%2bl7aSXqAfUuBvAmaAEQScY4xISWKHs%2bAZD69Sq6YpoXMqUEWgw7O3efuGVb3wExmEX4g95ddsJByA%3d%3d&crl=f&resultNs=AdminWebAuth&resultLocal=ErrCrlNotAuth&crlhashurl=login.aspx%3fdirect%3dtrue%26profile%3dehost%26scope%3dsite%26authtype%3dcrawler%26jrnl%3d17120934%26AN%3d18652215
57.
SweetC. M., & MaggioD. S. E. (2015). Do stronger intellectual property rights increase innovation?World Development, 66, 665–677. 10.1016/j.worlddev.2014.08.025
58.
SweetC., & EterovicD. (2019). Do patent rights matter? 40 years of innovation, complexity and productivity. World Development, 115, 78–93. 10.1016/j.worlddev.2018.10.009
59.
ThambisettyS., McMahonA., McDonaghL., KangH. Y., & DutfieldG. (2021). The TRIPS intellectual property waiver proposal: Creating the right incentives in patent law and politics to end the COVID-19 Pandemic (LSE Legal Studies Working Paper No. 06). http://dx.doi.org/10.2139/ssrn.3851737
60.
United Nations (UN). (2021, April9). Low-income countries have received just 0.2 per cent of all COVID-19 shots given. https://news.un.org/en/story/2021/04/1089392
61.
WooS., JangP., & KimY. (2015). Effects of intellectual property rights and patented knowledge in innovation and industry value added: A multinational empirical analysis of different industries. Technovation, 43, 49–63. 10.1016/j.technovation.2015.03.003
62.
World Trade Organisation (WTO). (1994, April15). Agreement on trade-related aspects of intellectual property rights (unamended). https://www.wto.org/english/docs_e/legal_e/27-trips.pdf
63.
YangC. H., HuangY. J., & LinH. Y. (2014). Do stronger intellectual property rights induce more innovations? A cross-country analysis. Hitotsubashi Journal of Economics, 55(22), 167–188. https://www.jstor.org/stable/43296295